Consensus Business Group (CBG)

www.cbg.uk.com

Foreign Investment Company

Tech Verticals Preferences

AgriTech, Biomed, Cleantech, Consumer-Oriented Software, Deep Tech, Defense Tech, Digital Health, Energy Tech, FinTech, FoodTech, Healthtech, Homeland Security, Life Sciences, Medical Devices, Semiconductors, Software Technologies

General Data

Established	2001
Current Active Portfolio Companies:	30

DESCRIPTION

Consensus Business Group (CBG) is a UK-based investment group with a net asset value exceeding $1.2 billion and a global investment footprint across strategic sectors.

CBG focuses on DefenseTech, DeepTech, Homeland Security, CleanTech, FinTech, and related innovation-driven industries, structuring sophisticated financial platforms to support transformative technologies. The group has deployed substantial capital into venture funds, incubators, holding companies, and direct investments worldwide, while building strong institutional ecosystems and cross-border partnerships.

In parallel, CBG is a significant real estate investor and asset manager in the UK, with one of the largest residential freehold portfolios in the country, representing over 1% of England’s housing stock.

AFFILIATION

Account ID	Affiliation Type	Name	Parent Name	Status
13A5DB50-207A-E111-AC59-00155D32A403		Consensus Business Group (CBG)
	Subsidiary	Aquila Investments Opportunity Ltd. (CBG)	Consensus Business Group (CBG)
F6F89067-C557-EA11-810A-0050569A1018	Subsidiary	Oriella Ltd.	Consensus Business Group (CBG)

REMARKS

Date	Remark
	Consensus fund of funds (carried out by Consensus Fund of Funds (CFF)) is focused on the following sectors: Buyouts, Technology, Life Sciences, Environment, Media and Industrial Services.
	Consensus direct investment activity is carried out by Consensus Community. This activity is focused on the following sectors: Environment, Technology, Homeland Security and Medical and Biotech.

CONTACT INFO

Expand / Collapse All

Main Address: London, United Kingdom

Address	35 Park Lane
City	London
Country	United Kingdom
Zip	W1K 1RB

Contact Person	abC Defghij
Contact E-Mail	abC Defghij
Company E-mail	abC Defghij
Telephone	abC Defghij
Fax	abC Defghij

	MANAGEMENT

Key Executive

Name	Title
Mr. Vincent Aziz Tchenguiz	Chairman, Director & Founder
Mr. Rotem Yehuda Kakon	Strategic Investor and Portfolio Manager
Ms. Merav Kaye	Head of Tech Investments

Preferences

Type of Financing	Equity,Investments in Funds
Stage Preferences	Initial Revenues,R&D,Revenue Growth,Seed

SECTOR SEGMENTATION (By Number Of Companies)

Medical Devices

24%

Biomed

20%

Cleantech

16%

Agritech

12%

Digital Health

Energy

Hardware & Industrial

Consumer-Oriented Software

Network Infrastructure

	PORTFOLIO COMPANIES

Current Portfolio Companies (30)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

Adicet Bio

Biomed

Second Round

02/10/2019

N/A

$80m

Arcuro

First Round - Extended

30/09/2024

N/A

$5m

Arrow Operations and Technologies

Arrow Operations & Technologies Ltd. specializes in the treatment and recycling of industrial wastewater and sludge using cutting-edge, safe and eco-friendly technology and applications.

Cln.

First Round

01/03/2001

N/A

$5m

BiomX

Biomed

Second Round

20/02/2019

N/A

$32m

BioProtect

$BioProtect is advancing rectal spacing using controllable balloon technology. The company’s proprietary biodegradable balloon spacer is designed to provide consistent, predictable separation from apex to base, supporting both safe and advanced radiation therapy. The first product, the BioProtect Balloon Implant, has received FDA clearance for use in prostate cancer. Clinical studies have demonstrated reduced rectal dose and favorable safety profiles, supporting the delivery of modern treatment strategies, including hypofractionation and SBRT.$

Fifth Round	27/09/2023	N/A	$28m
Fourth Round - Extended	22/09/2020	N/A	$12m
Fourth Round	01/05/2019	$7m	$13m

Capital Nature

N/A

Investment in Fund	07/07/2019	$5m	$6m	Through Oriella Ltd.
Investment in Fund	01/01/2012	N/A	N/A

Celleste Bio

Celleste produces real, chocolate-grade cocoa butter & powder using cell-cultured technology to stabilize supply and future-proof the global cocoa industry.
Celleste was founded with the mission to meet the world’s rising demand for chocolate in the face of supply chain challenges created by climate change and outdated conventional farming practices. Celleste uses a combination of AgTech, BioTech and AI computational models to grow 100% natural cocoa from just one or two beans, in optimal, controlled conditions. This enables production of high-quality cocoa butter and powder, year-round, without having to cut down a single tree.

Agri

Seed - Extended

05/12/2024

N/A

$4.5m

Edge Labs

N/A

Investment in Fund

01/01/2025

N/A

Enervibe

Energy

First Round

01/02/2022

N/A

$3.4m

Exero Medical

Seed - Extended	13/02/2025	N/A	$10m
Seed - Extended	01/06/2024	N/A	$3.5m
Seed - Extended	15/12/2021	N/A	$1.3m

IBI-Ag

Agri

First Round - Extended	11/11/2025	N/A	$3.9m
First Round	13/02/2025	N/A	$6.1m

Make My Day

CO SW

First Round

16/11/2021

N/A

$4.3m

MediSafe

Dig. Health

Third Round - Extended	09/03/2023	N/A	N/A
Third Round	17/02/2021	N/A	$30m

MedX

N/A

Investment in Fund

28/07/2021

$20m

Minovia

Biomed

Second Round

01/03/2019

N/A

$6m

NewRocket

HW & Indust.

First Round

03/12/2020

$1m

NGT Healthcare II

N/A

Investment in Fund

22/02/2022

N/A

$92m

Omnix Medical

Biomed

Third Round	15/10/2025	N/A	$25m
Second Round	03/11/2020	N/A	$8.5m
First Round	01/12/2018	N/A	$6.5m

Owlytics

Dig. Health

First Round

26/12/2019

N/A

$4m

Phytolon

Agri

First Round - Extended	05/10/2023	N/A	N/A
Seed - Extended	16/09/2020	N/A	$4.1m

PregnanTech

Seed - Extended

01/12/2020

N/A

$1.05m

RepAir

Cln.

First Round - Extended	15/03/2025	N/A	$15m
First Round	06/12/2022	N/A	$10m
Seed	06/10/2021	N/A	$1.5m

Revamp

First Round

25/10/2020

N/A

Setpoint

Energy

Seed - Extended	13/05/2020	N/A	$3m
Seed - Extended	01/12/2019	N/A	$1.7m

Synchrony Medical

Synchrony is a developer of a respiratory therapy device, designed to provide treatment for chronic obstructive pulmonary disease (COPD). The company's device provides remote monitoring and treatment of COPD patients, which involves manual respiratory physiotherapy, enabling patients to have tailored, adaptive home therapy for improving lung function and clearing their airways.

First Round

01/08/2024

N/A

Tenna

Network Infra.

Seed - Extended

15/01/2026

N/A

$11.5m

TPCera

Biomed

First Round

29/11/2018

N/A

TripleW

Cln.

Second Round	22/03/2023	N/A	$16.5m
First Round - Extended	26/04/2021	$0.85m	$5m

VLX Ventures

VLX (Van Leer Xenia) Ventures was formed as a partnership between Xenia Venture Capital and Van Leer Ventures, two leading Israeli early-stage investment centers, to jointly operate a technological incubator in Jerusalem and initiate and build-up innovative start-up companies in Israel. VLX ventures specializes in the fields of High-Tech (incl. SW, IoT, Communication & Mobile, Big Data, Video, etc.), and Life Sciences, as well as the combination of the two – Digital Health. Its team provides entrepreneurs with extensive mentoring and networking support. Its experience and know how, combined with financial backing and administrative assistance give early-stage startups the encouragement and financing they need to grow and thrive.

N/A

Investment in Fund

01/01/2016

N/A

WINT

Cln.

Third Round	10/08/2023	N/A	$35m
Second Round	11/12/2021	N/A	$15m

Current VC Fund Portfolio (12)

Fund Name

Fund Type

Date Announced

Amount

Remarks

ALIVE Fund

Venture Capital Fund

01/07/2020

N/A

Earth & Beyond...

Venture Capital Fund

01/08/2022

N/A

EdgeMed

Venture Capital Fund

01/06/2024

N/A

Hyperion

Venture Capital Fund

01/01/2000

N/A

Infinity I-China

Venture Capital Fund

01/01/2006

N/A

Israel Biotech Fund...

Venture Capital Fund

16/07/2019

N/A

Medica II

Venture Capital Fund

01/01/2000

N/A

Medica III

Venture Capital Fund

01/01/2005

N/A

Mensch Capital...

Venture Capital Fund

01/08/2021

N/A

Peregrine II

Venture Capital Fund

01/09/2006

N/A

Trendlines Agrifood

Venture Capital Fund

24/09/2019

N/A

Through Librae Holdings/Trendfood, as part of CBG

Viola Credit III

Venture Lending Fund

01/01/2007

N/A

Exits (11)

Company Name	Exit Type	Date Announced	Amount	Remarks
abC Defghij (Investment Company)	IPO	29/10/2021	abCDe	$16.5 from exercised underwriters' option to purchase additional units at the initial public offering price to cover over-allotments (green shoe options)
abC Defghij	Acquired	26/07/2025	abCDe	The total value of the acquisition could grow to $250m, contingent on Cynerio achieving specific milestones. As part of the acquisition deal, RDC received 0.6% of Axonius' shares.
abC Defghij	IPO	28/01/2007	abCDe	Including shares and convertible debentures
abC Defghij	IPO	13/12/2021	abCDe	Raised NIS 162m; Post Valuation NIS 794m
abC Defghij	Acquired	31/12/2018	abCDe
abC Defghij (Incubator)	Holdings Sold		abCDe
abC Defghij	Acquired	16/10/2008	abCDe	10/2009: Omniture was acquired by Adobe Systems Inc.
abC Defghij	IPO	30/06/2020	abCDe	Includes greenshoe options ($9m).
abC Defghij	Acquired	01/07/2017	abCDe
abC Defghij (Venture Lending Fund)	Holdings Sold	01/01/2009	abCDe
abC Defghij	Holdings Sold		abCDe

Historic Portfolio (6)

Company Name

Sector

Round/Deal Type

Date Announced

Investor Amount

Total Deal Amount

Remarks

AQI

Ceased to Operate

HW & Indust.

First Round

01/10/2001

N/A

AquAgro I

N/A

Investment in Fund

01/01/2007

N/A

$50m

Hemisens

Ceased to Operate

First Round

01/01/2020

N/A

Pi Therapeutics

Ceased to Operate

Biomed

Second Round

29/05/2019

N/A

$19.7m

SenterCare

Ceased to Operate

Dig. Health

Seed

01/02/2020

N/A

$1m

Simetria

Ceased to Operate

Ent. SW

First Round

11/08/2022

N/A

$2m

Last Updated:	abCDe
IVC Number:	abCDe